People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Enterin, Inc. | — | Biotechnology | Series B | $50.7M | $47.2M | 2017 |
| Coaxia Inc | — | Biotechnology | Series B | $40.0M | $893.0M | 2009 |
| BeneChill, Inc. | — | Other Health Care | Series A | $35.7M | $132.7M | 2009 |
| Sarentis Therapeutics Inc | — | Pharmaceuticals | Seed | $4.4M | $28.5M | 2009 |
| Astuce, Inc. | — | Other Health Care | Pre-Seed | $900K | $18.5M | 2012 |
| Sarentis Ophthalmic Inc | — | Other Health Care | Pre-Seed | $426K | $13.1M | 2012 |
| Clepsydra, Inc. | — | Other Health Care | Pre-Seed | $300K | $9.2M | 2012 |
| Enigma Medical, Inc. | — | Other Health Care | Pre-Seed | $300K | $9.2M | 2012 |
| Vigilant Medical Solutions, Inc. | — | Other Health Care | Pre-Seed | $300K | $9.2M | 2012 |
Denise Barbut at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Denise Barbut on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.